Kelly C. Goldsmith, MD
Director of Neuroblastoma/MIBG Therapy Program,
Clinical Director of Aflac Precision Medicine Program,
Aflac Cancer & Blood Disorders Center
Children’s Healthcare of Atlanta
Associate Professor of Pediatrics,
Emory University School of Medicine
Education and Training
Medical Degree: University of Alabama School of Medicine, Birmingham, AL, 1995-1999.
Residency: Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, 1999-2002.
Fellowship: Pediatric Hematology/Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, 2002-2005.
Pediatric Hematology/Oncology American Board of Pediatrics
Professional Scientific Societies
American Society of Pediatric Hematology and Oncology, Member; American Association for Cancer Research, Member; American Society of Clinical Oncology, Member; Children’s Oncology Group, Member
American Cancer Society Mentored Research Scholars Awardee, 2008; ASCO Young Investigator Award, 2005; Caitlin Robb Foundation Award, 2004; Italian Neuroblastoma Foundation Award—Advances in Neuroblastoma Research Meeting, Genoa, Italy, 2004
Areas of Interest
Neuroblastoma, Wilms tumor and other renal tumors of childhood